Therapeutic HPV vaccine Phase Ib trial completes recruitment; H5N1 vaccine into Phase III in Vietnam;

> Vietnamese researchers have moved an H5N1 vaccine into Phase III studies, after positive results from Phase I and II trials. Blog post

> Protein Sciences has granted Merck ($MRK) a non-exclusive license to its expresSF+ serum-free insect cell line for vaccine research. Press release

> A University of Alberta researcher has discovered a potential hepatitis C vaccine; there is currently no vaccine available. Press release

> French biopharma company Genticel has completed recruitment of a Phase Ib trial of ProCervix, its therapeutic HPV vaccine designed for women already infected with the virus. Press release

> Increased use of pneumococcal vaccines in children seems to have cut levels of invasive pneumococcal disease in people with HIV. Abstract

> The International AIDS Vaccine Initiative (IAVI) has awarded $875,000 in grants to two researchers identified through NineSigma's Open Innovation process. Press release

> Novartis Vaccines and Diagnostics has withdrawn its application to the European Medicines Agency for a pediatric marketing authorization for Fluad Paediatric (influenza vaccine). Press release

And Finally… Chagas' disease vaccine for pets could prevent spread of the disease to humans. Press release